Cyclophosphamide can treat SLE by targeting activated B cells that are undergoing proliferation,47 monoclonal antibodies to CD20 and CD22 have been used to deplete B cells in SLE patients and lupus mice.48 This evidence concerns the gene CD22 and systemic lupus erythematosus.